Department Of Biotechnology

India readies five sites for final phase of human trials of Oxford's COVID-19 vaccine

Serum Institute of India has been chosen by Oxford University and its partner AstraZeneca to manufacture the COVID-19 vaccine

COVID-19 vaccine in India: Government to set guidance document for trials of vaccines, treatment

No process in vaccine development trials will be skipped, but approvals to carry out multiple phases of trials parallelly may be given.

Three companies shortlisted to receive funding to develop Coronavirus vaccines from Department of Biotech

From over 500 applications, DBT selected Cadila Healthcare Ltd, Bharat Biotech International Ltd and Serum Institute of India Private Limited.

ICMR will set up two rapid testing labs, 49 additional testing centers for coronavirus diagnosis

The rapid testing labs, able to test around 1,400 samples per day, will be set up Delhi-NCR and Bhubaneswar.

Nanotechnology promises less damage, better benefits for agricultural produce

The government is turning to nanobiotechnology for low-cost, high-efficacy solutions to agricultural challenges.

IIT-Kharagpur to steer EU-funded project for treating, reusing wastewater; 'will evaluate effectiveness of different technology,’ says professor

Project is being funded by EU, Government of India's Department of Science and Technology and Department of Biotechnology

European Union and India to work hand in hand to develop influenza vaccine

Both the EU and the Department of Biotechnology, Govt. of India will engage in developing a vaccine.

DST has introduced a new scheme to promote participation of women in the fields of science and technology

DST and Indo-US Science & Technology Forum (IUSSTF) have jointly announced the Indo-US Fellowship for Women in STEMM.

New initiatives to boost technology incubators

The government has decided to set up 15 new biotechnology incubators and another 15 new technology business incubators during the coming financial year.

War on dengue gets new edge: Scientists develop antiviral to tackle all four types of disease

Scientists at the New Delhi-based ICGEB are in the final stages of developing a new antiviral that promises to tackle all the four types of dengue virus.